Simulations Plus, Inc. SLP
Simulations Plus, Inc. was incorporated in California on July 17, 1996. The Company is a global leader and premier provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery and development, clinical trial operations, and commercialization. The Company supports its clients across the drug development lifecycle from early discovery through all phases of clinical research and development ("R&D"), including clinical operations, to product commercialization. The Company serves clients as a strategic partner throughout the entire drug development lifecycle, offering solutions that integrate scientific software platforms, artificial intelligence-augmented insights, and expert consulting. This optimizes efficiency, costs, and time-to-market for our clients, thereby enhancing our competitive position.
Valuation FY2025 figures against the last close
Where the revenue comes from as reported in the latest 10-K
Revenue by geography
- Americas
- Emea
- Asia Pacific
| Region | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Americas | $57.7M | $50.5M | $40.8M |
| Emea | $14.2M | $14.1M | $11.7M |
| Asia Pacific | $7.3M | $5.5M | $7.0M |
As the company reported it, from the “SEGMENT REPORTING - Schedule of Geographical Revenues (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Regions are the filer's own and are not mapped onto a standard list — one company's “Americas” and another's “United States” are different areas, and making them look comparable would mean making at least one of them wrong. Slices under 1% are folded into “Other”.
Revenue by segment
- Software
- Services
| Segment | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Software | $45.8M | $41.0M | $36.5M |
| Services | $33.4M | $29.0M | $23.1M |
As the company reported it, from the “SEGMENT REPORTING - Schedule of Business Unit Segment And Consolidated Results (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Segments are the filer's own reporting structure, which is a decision about how it runs itself rather than a standard taxonomy: two companies in the same industry routinely divide themselves along different lines, so these are worth reading down a single company rather than across two. Slices under 1% are folded into “Other”.
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $79.2M | $70.0M | $59.6M | $53.9M | $46.5M | $41.6M | $34.0M | $29.7M | $24.1M | $20.0M |
| Cost of revenue | $33.0M | $26.9M | $11.6M | $10.8M | $10.6M | $10.6M | $9.0M | $8.0M | $6.3M | $4.6M |
| Gross profit | $46.2M | $43.2M | $47.9M | $43.1M | $35.9M | $30.9M | $24.9M | $21.7M | $17.8M | $15.4M |
| R&D | $6.9M | $5.8M | $4.5M | $3.2M | $4.0M | $3.0M | $2.5M | $1.8M | $1.4M | $1.4M |
| SG&A | $20.9M | $22.4M | $27.7M | $20.1M | $20.6M | $16.4M | $11.8M | $9.6M | $8.2M | $6.7M |
| Total operating expenses | $117.0M | $37.0M | $39.2M | $28.2M | $24.6M | $19.3M | $14.3M | $11.4M | $9.6M | $8.1M |
| Operating income | -$70.7M | $6.1M | $8.7M | $14.9M | $11.3M | $11.6M | $10.6M | $10.3M | $8.3M | $7.2M |
| Interest expense | — | — | — | — | $22.0K | $0 | $0 | $153.0K | $38.2K | $0 |
| Pre-tax income | -$69.4M | $12.4M | $11.7M | $15.1M | $11.1M | $11.4M | $10.6M | $10.1M | $8.2M | $7.2M |
| Income tax | $4.7M | $2.5M | $1.7M | $2.6M | $1.3M | $2.1M | $2.0M | $1.2M | $2.5M | $2.3M |
| Net income | -$64.7M | $10.0M | $10.0M | $12.5M | $9.8M | $9.3M | $8.6M | $8.9M | $5.8M | $5.0M |
| EPS, basic | -3.22 | 0.50 | 0.50 | 0.62 | 0.49 | 0.52 | 0.49 | 0.52 | 0.34 | 0.29 |
| EPS, diluted | -3.22 | 0.49 | 0.49 | 0.60 | 0.47 | 0.50 | 0.48 | 0.50 | 0.33 | 0.29 |
| Shares, diluted (wtd. avg.) | 20.1M | 20.3M | 20.5M | 20.7M | 20.7M | 18.5M | 18.1M | 17.9M | 17.5M | 17.2M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $30.9M | $10.3M | $57.5M | $51.6M | $37.0M | $49.2M | $11.4M | $9.4M | $6.2M | $8.0M |
| Short-term investments | $1.5M | $9.9M | $57.9M | $76.7M | $86.6M | $66.8M | $0 | — | — | — |
| Receivables | $9.7M | $9.1M | $10.2M | $13.8M | $9.9M | $7.4M | $5.0M | $5.5M | $4.0M | $3.0M |
| Total current assets | $51.5M | $39.3M | $130.4M | $146.8M | $139.3M | $129.1M | $21.2M | $17.8M | $12.7M | $12.7M |
| Property, plant and equipment | $880.0K | $812.0K | $671.0K | $632.0K | $1.8M | $438.0K | $341.1K | $335.2K | $291.1K | $256.4K |
| Goodwill | $43.7M | $96.1M | $19.1M | $12.9M | $12.9M | $12.9M | $10.4M | $10.4M | $10.4M | $4.8M |
| Other intangibles | — | — | — | — | $10.5M | $11.9M | $5.0M | $5.9M | $6.8M | $4.7M |
| Total assets | $131.9M | $196.6M | $186.1M | $188.4M | $180.0M | $168.4M | $45.2M | $43.3M | $38.5M | $27.8M |
| Accounts payable | $470.0K | $602.0K | $144.0K | $225.0K | $387.0K | $351.0K | $204.1K | $351.6K | $240.9K | $108.1K |
| Short-term debt | — | — | — | — | — | — | — | $2.6M | $247.3K | — |
| Total current liabilities | $6.7M | $12.1M | $12.0M | $7.7M | $11.6M | $5.5M | $4.8M | $4.8M | $2.0M | $2.1M |
| Long-term debt | — | — | — | — | — | — | — | $3.3M | $5.7M | — |
| Total liabilities | $7.1M | $14.2M | $16.1M | $10.1M | $14.2M | $12.4M | $7.5M | $11.4M | $12.7M | $5.1M |
| Retained earnings | -$34.4M | $30.4M | $25.2M | $40.0M | $32.4M | $27.4M | $22.4M | $18.5M | $13.7M | $11.3M |
| Total equity | $124.8M | $182.4M | $170.0M | $178.2M | $165.8M | $156.0M | $37.7M | $31.9M | $25.8M | $22.7M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $18.1M | $13.3M | $21.9M | $17.9M | $19.2M | $10.9M | $11.6M | $9.3M | $6.9M | $5.4M |
| Depreciation and amortisation | $300.0K | $300.0K | $200.0K | $300.0K | $200.0K | $200.0K | $132.0K | $139.2K | $2.1M | $1.9M |
| Stock-based compensation | $6.4M | $6.5M | $4.8M | $3.0M | $2.8M | $1.6M | $1.1M | $709.1K | $621.8K | $347.1K |
| Capital expenditure | $713.0K | $566.0K | $453.0K | $819.0K | $1.6M | $231.0K | $138.0K | $183.3K | $176.0K | $39.1K |
| Investing cash flow | $3.6M | -$54.0M | $7.4M | $4.3M | -$26.7M | -$75.5M | -$2.0M | -$2.3M | -$4.4M | -$2.0M |
| Financing cash flow | -$1.1M | -$6.6M | -$23.3M | -$7.6M | -$4.7M | $102.4M | -$7.6M | -$3.8M | -$4.3M | -$4.0M |
| Dividends paid | $0 | $4.8M | $4.8M | $4.8M | $4.8M | $4.2M | $4.2M | $4.2M | $3.4M | $3.4M |
| Buybacks | $0 | $0 | $20.0M | $0 | $0 | — | — | — | — | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001023459-25-000060.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.0M | $24.1M | $29.7M | $34.0M | $41.6M | $46.5M | $53.9M | $59.6M | $70.0M | $79.2M |
| Gross profit | $15.4M | $17.8M | $21.7M | $24.9M | $30.9M | $35.9M | $43.1M | $47.9M | $43.2M | $46.2M |
| Net income | $5.0M | $5.8M | $8.9M | $8.6M | $9.3M | $9.8M | $12.5M | $10.0M | $10.0M | -$64.7M |
Recent filings and events
- Shareholder vote The results of the annual meeting or a special vote. Item 5.07
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
- Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
- Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Regulation FD disclosure Item 7.01
- Results announced Item 2.02
- Regulation FD disclosure Item 7.01
- Officer or director change Item 5.02
- Shareholder vote Item 5.07
- Results announced Item 2.02
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 7373
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| IOT | Samsara Inc. | $26.14B | — | 29.6% |
| LDOS | Leidos Holdings, Inc. | $17.08B | 12.2x | 3.2% |
| GDDY | GoDaddy Inc. | $14.28B | 18.1x | 8.3% |
| CACI | CACI INTERNATIONAL INC /DE/ | $14.01B | 26.2x | 10.9% |
| IONQ | IonQ, Inc. | $11.91B | — | 201.9% |
| JKHY | JACK HENRY & ASSOCIATES INC | $11.40B | 23.3x | 7.1% |
| AUR | Aurora Innovation, Inc. | $9.50B | — | — |
| OTEX | OPEN TEXT CORP | $6.77B | 10.8x | 1.5% |